Automated insulin systems outperform traditional diabetes management methods

Embargoed until: Publicly released: 2025-03-20 00:40

International

Photo by Towfiqu barbhuiya on Unsplash

An automated insulin delivery system has outperformed traditional insulin delivery methods in a trial with 319 type 2 diabetes patients. International researchers divided the participants in a 2:1 ratio - the larger group received the automated insulin delivery system, consisting of an automated insulin pump and continuous glucose monitor, while the rest continued their usual insulin delivery method over 13 weeks. Monitoring the participants' glucose levels throughout the trial, the researchers say the participants using the automated system saw a greater reduction in blood sugar levels compared to the control group, and the automated delivery group spent more time within their target glucose range. The researchers say their study shows this automated system can be used safely and can be beneficial for diabetes management.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Massachusetts Medical Society, Web page The URL will go live after the embargo ends

Journal/
conference: New England Journal of Medicine

Research:Paper

Organisation/s: Mayo Clinic, USA

Funder: Supported by Tandem Diabetes Care. Novo Nordisk provided the insulin aspart that was used in the trial. Continuous glucose monitor sensors and transmitters were purchased from Dexcom at a discounted price.

Media Contact/s

Contact details are only visible to registered journalists.